P43490 (NAMPT_HUMAN) Homo sapiens (Human)
Nicotinamide phosphoribosyltransferase UniProtKBInterProSTRINGInteractive Modelling
491 aa; Sequence (Fasta) ;
1 identical sequence: Gorilla gorilla gorilla: A0A2I2Z4X6
It is possible new templates exist for this target since these models were created.
Available Structures
82 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Human NAMPT in complex with quercitrin and AMPcP | homo-2-mer | 100.0 | 2×A12; 2×QCT; | |||
| Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) … | homo-2-mer | 100.0 | 2×1QR; 6×PO4; 10×EDO; | |||
| Discovery of Potent and Efficacious Cyanoguanidine-containing Nicotinamide Phosphoribosyltransferas… | homo-2-mer | 100.0 | 2×LTS; 2×PO4; 9×EDO; | |||
| Structural Analysis of a Phosphoribosylated Inhibitor in Complex with Human Nicotinamide Phosphorib… | homo-2-mer | 100.0 | 2×1XC; 4×PO4; 3×EDO; | |||
| Discovery of Potent and Efficacious Urea-containing Nicotinamide Phosphoribosyltransferase (NAMPT) … | homo-2-mer | 100.0 | 2×1LJ; 4×PO4; 10×EDO; | |||
| Identification of Amides Derived From 1H-Pyrazolo[3,4-b]pyridine-5-carboxylic Acid as Potent Inhibi… | homo-2-mer | 100.0 | 2×20R; 2×PO4; | |||
| Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic A… | homo-2-mer | 100.0 | 4×20J; 4×PO4; 2×EDO; | |||
| Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived Ureas as Potent Inhibitors of Human… | homo-2-mer | 100.0 | 2×1R7; 4×PO4; 7×EDO; | |||
| Human NAMPT in complex with small molecule activator ZN-43-S | homo-2-mer | 100.0 | 2×PO4; 3×GOL; 2×TKF; 1×CL; | |||
| Structural and Biochemical Analyses of the Catalysis and Potency Impact of Inhibitor Phosphoribosyl… | homo-2-mer | 100.0 | 2×2QG; 3×PO4; | |||
| Human NAMPT in complex with substrate NAM | homo-2-mer | 100.0 | 2×NCA; 2×PO4; 1×GOL; 3×CL; | |||
| NAMPT co-crystal with inhibitor compound 2 | homo-2-mer | 100.0 | 2×PO4; 2×HVM; | |||
| Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic A… | homo-2-mer | 100.0 | 2×20P; 2×PO4; 16×EDO; | |||
| Structural and Biochemical Analyses of the Catalysis and Potency Impact of Inhibitor Phosphoribosyl… | homo-2-mer | 100.0 | 2×2QF; 4×PO4; 13×EDO; | |||
| Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic A… | homo-2-mer | 100.0 | 2×20M; 6×PO4; 12×EDO; | |||
| Crystal Structure of Nicotinamide Phosphoribosyltransferase (Nampt) in Complex with Inhibitors 37 | homo-2-mer | 100.0 | 2×6TA; 6×PO4; 9×EDO; | |||
| Structure-Based Discovery of Novel Amide-Containing Nicotinamide Phosphoribosyltransferase (Nampt) … | homo-2-mer | 100.0 | 2×1QS; 4×PO4; 10×EDO; | |||
| Discovery of Potent and Efficacious Cyanoguanidine-containing Nicotinamide Phosphoribosyltransferas… | homo-2-mer | 100.0 | 2×LWW; 4×PO4; 19×EDO; | |||
| The crystal structure of a mutant NAMPT (G217R) in complex with an inhibitor APO866 | homo-2-mer | 99.79 | 2×DGB; 4×PO4; 11×EDO; | |||
| Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide … | homo-2-mer | 100.0 | 2×2HJ; 2×PO4; 6×EDO; | |||
| Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic A… | homo-2-mer | 100.0 | 2×20O; 6×PO4; 10×EDO; | |||
| Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors | homo-2-mer | 99.79 | 2×DGB; 4×PO4; 15×EDO; | |||
| Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide … | homo-2-mer | 100.0 | 2×2HL; 2×PO4; 20×EDO; 2×DTT; | |||
| The crystal structure of human Nicotinamide phosphoribosyltransferase (NAMPT) in complex with N-(4-… | homo-2-mer | 100.0 | 2×3TQ; 4×PO4; 13×EDO; | |||
| The crystal structure of a mutant NAMPT (G217V) | homo-2-mer | 99.79 | 2×PO4; 11×EDO; | |||
| The crystal structure of NAMPT in complex with GNE-618 | homo-2-mer | 100.0 | 2×2P1; 4×PO4; 8×EDO; | |||
| Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide … | homo-2-mer | 100.0 | 2×2ZM; 2×PO4; | |||
| Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors | homo-2-mer | 99.79 | 2×1XC; 4×PO4; 26×EDO; | |||
| The crystal structure of a mutant NAMPT (S165F) in complex with GNE-618 | homo-2-mer | 99.78 | 2×2P1; 4×PO4; 3×EDO; | |||
| Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors | homo-2-mer | 99.79 | 2×PO4; 8×EDO; | |||
| Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic A… | homo-2-mer | 100.0 | 2×20N; 2×PO4; 3×EDO; | |||
| The crystal structure of the mutant NAMPT G217R | homo-2-mer | 99.79 | 4×PO4; 8×EDO; | |||
| Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors | homo-2-mer | 99.79 | 2×PO4; 8×EDO; | |||
| Structure-based Identification of Ureas as Novel Nicotinamide Phosphoribosyltransferase (Nampt) Inh… | homo-2-mer | 100.0 | 2×1LS; 4×PO4; 2×EDO; | |||
| Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors | homo-2-mer | 99.79 | 4×PO4; 2×EDO; | |||
| Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors | homo-2-mer | 99.78 | 2×1QS; 4×PO4; 13×EDO; | |||
| Structural and Biochemical Analyses of the Catalysis and Potency Impact of Inhibitor Phosphoribosyl… | homo-2-mer | 100.0 | 2×2RM; 4×PO4; | |||
| The crystal structures of a mutant NAMPT H191R | homo-2-mer | 99.79 | 2×PO4; 2×EDO; | |||
| Identification of Amides Derived From 1H-Pyrazolo[3,4-b]pyridine-5-carboxylic Acid as Potent Inhibi… | homo-2-mer | 100.0 | 2×20T; 2×POP; 2×PO4; | |||
| Structural Analysis of a Phosphoribosylated Inhibitor in Complex with Human Nicotinamide Phosphorib… | homo-2-mer | 100.0 | 2×1XD; 4×PO4; 2×EDO; | |||
| Fragment-based Identification of Amides Derived From trans-2-(Pyridin-3-yl)cyclopropanecarboxylic A… | homo-2-mer | 100.0 | 4×PO4; 2×1EB; 1×EDO; | |||
| Human NAMPT in complex with substrate NAM and small molecule activator ZN-29-S | homo-2-mer | 100.0 | 2×NCA; 2×PO4; 2×XI3; 1×CL; | |||
| Crystal Structure of human NAMPT in complex with NVP-LVR596 | homo-2-mer | 100.0 | 2×CVJ; 6×PO4; | |||
| Crystal Structure of human NAMPT in complex with NVP-LOD812 | homo-2-mer | 100.0 | 2×BWA; 2×GOL; 2×PO4; | |||
| Fragment-based Design of 3-Aminopyridine-derived Amides as Potent Inhibitors of Human Nicotinamide … | homo-2-mer | 100.0 | 2×PO4; 2×2HH; | |||
| Human NAMPT in complex with substrate NAM and small molecule activator NP-A1-R | homo-2-mer | 100.0 | 2×NCA; 2×PO4; 2×TIE; 3×GOL; 3×CL; 1×NA; | |||
| Human NAMPT in complex with substrate NAM and activator quercitrin | homo-2-mer | 100.0 | 2×NCA; 3×CL; 2×PO4; 2×QCT; | |||
| Human NAMPT in complex with substrate NAM and small molecule activator NP-A1-S | homo-2-mer | 100.0 | 2×NCA; 2×PO4; 2×TIW; 3×CL; 1×GOL; | |||
| Human NAMPT in complex with substrate NAM and small molecule activator NP-A3 | homo-2-mer | 100.0 | 2×GOL; 2×NCA; 2×I7Q; 3×CL; 2×PO4; | |||
| Crystal Structure of human NAMPT in complex with NVP-LTM976 | homo-2-mer | 100.0 | 2×OE4; 6×PO4; | |||
| Human NAMPT in complex with inhibitor ZN-4-3 | homo-2-mer | 100.0 | 2×TK0; 2×PO4; 2×CL; 1×GOL; | |||
| Human NAMPT in complex with nicotinic acid and phosphoribosyl pyrophosphate | homo-2-mer | 100.0 | 2×PRP; 2×GOL; 2×NIO; | |||
| Human NAMPT deletion mutant in complex with nicotinamide mononucleotide, pyrophosphate, and Mg2+ | homo-2-mer | 100 | 1×GOL; 4×MG; 2×NMN; 2×PPV; | |||
| Crystal structure of human NAMPT with A-1326133 | homo-2-mer | 100.0 | 6×SO4; 2×7TA; | |||
| Crystal Structure of Human NMPRTase in complex with FK866 | homo-2-mer | 100.0 | 2×DGB; | |||
| Crystal Structure of human NAMPT in complex with NVP-LQN520 | homo-2-mer | 100.0 | 2×C5V; | |||
| Human NAMPT in complex with nicotinic acid mononucleotide and phosphate | homo-2-mer | 100.0 | 1×GOL; 2×NCN; 2×PO4; 2×CL; | |||
| Crystal structure of human NAMPT with isoindoline urea inhibitor compound 53 | homo-2-mer | 100.0 | 2×8HV; | |||
| CRYSTAL STRUCTURE OF NAMPT IN COMPLEX WITH Compound 10 | homo-2-mer | 100.0 | 2×7YE; 4×PO4; 4×GOL; | |||
| Crystal structure of phosphorylated mimic form of human NAMPT complexed with nicotinamide mononucle… | homo-2-mer | 100.0 | 4×MG; 2×NMN; 2×BEF; 2×POP; | |||
| CRYSTAL STRUCTURE OF NAMPT IN COMPLEX WITH COMPOUND 1 | homo-2-mer | 100.0 | 6×PO4; 2×7YK; 2×GOL; | |||
| Crystal structure of phosphorylated mimic form of human NAMPT complexed with benzamide and phosphor… | homo-2-mer | 100.0 | 4×MG; 2×UNU; 2×BEF; 2×PRP; | |||
| Crystal structure of human NAMPT with A-1293201 | homo-2-mer | 100.0 | 2×7T7; 6×SO4; | |||
| Crystal structure of human NAMPT with isoindoline urea inhibitor compound 5 | homo-2-mer | 100.0 | 2×8HY; | |||
| Crystal structure of human NAMPT complexed with benzamide and phosphoribosyl pyrophosphate | homo-2-mer | 100.0 | 2×PRP; 2×UNU; | |||
| Crystal structure of Human NMPRTase as free-form | homo-2-mer | 100.0 | ||||
| Crystal structure of human NAMPT complexed with nicotinamide mononucleotide and pyrophosphate | homo-2-mer | 100.0 | 4×MG; 2×NMN; 2×POP; | |||
| Crystal structure of Human NMPRTase complexed with nicotinamide | homo-2-mer | 100.0 | 2×NCA; | |||
| Co-crystal structure of NAMPT dimer with KPT-9274 | homo-2-mer | 100.0 | 2×PO4; 14×GOL; 2×96Q; | |||
| Crystal Structure of Human NAMPT in complex with A4276 | homo-2-mer | 100.0 | 2×SJ6; 6×PO4; | |||
| Crystal structure of human NAMPT complexed with ADP analogue | homo-2-mer | 100.0 | 2×A12; | |||
| CRYSTAL STRUCTURE OF NAMPT IN COMPLEX WITH COMPOUND 9 | homo-2-mer | 100.0 | 3×PO4; 2×7YX; 3×EDO; | |||
| Crystal Structure of human NMPRTase and its complex with NMN | homo-2-mer | 100.0 | 4×PO4; 2×NMN; | |||
| Crystal structure of Human NMPRTase complexed with 5'-phosphoribosyl-1'-pyrophosphate | homo-2-mer | 100.0 | 2×PRP; | |||
| Crystal structure of human NAMPT in complex with compound NAT | homo-2-mer | 100.0 | 2×J7F; 3×PO4; | |||
| CRYSTAL STRUCTURE OF NAMPT IN COMPLEX WITH COMPOUND 8 | homo-2-mer | 100.0 | 2×PO4; 2×7YT; 4×EDO; | |||
| Crystal Structure of human NAMPT in complex with NVP-LOQ594 | homo-2-mer | 100.0 | 2×CVP; | |||
| CRYSTAL STRUCTURE OF VISFATIN IN COMPLEX WITH SAR154782-RP. | homo-2-mer | 100.0 | 2×7A0; 2×DPO; | |||
| CRYSTAL STRUCTURE OF VISFATIN IN COMPLEX WITH SAR154782. | homo-2-mer | 100.0 | 2×7A1; | |||
| Crystal STRUCTURE OF NAMPT IN COMPLEX WITH Compound 11 | homo-2-mer | 100.0 | 2×7Z2; 2×PO4; 4×CL; 1×GOL; | |||
| Crystal structure of human NAMPT with fragment 5: (3E)-3-[(phenylamino)methylidene]oxan-2-one | monomer | 100.0 | 1×AOY; 1×SO4; | |||
| Crystal structure of human NAMPT with fragment 2: 2-[(2-fluorophenyl)amino]-6-propylpyrimidin-4(3H)… | monomer | 100.0 | 1×AQ1; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7ppe.1.A | homo-2-mer | 0.90 | 2×7YK; | 100.00 | ||